Skip to main content

Table 1 Demographic of patients with septic shock divided by low- or high-renal replacement therapy (RRT) intensive care units (ICUs)

From: Variation in the use of renal replacement therapy in patients with septic shock: a substudy of the prospective multicenter observational FINNAKI study

 

Patients in low-RRT ICUs (n = 372)

Patients in high-RRT ICUs (n = 354)

P value

Age (years)

64.0 [54.0–74.0]

67.0 [56.0–76.0]

0.04

Gender (male)

243 (65.3)

221 (62.4)

0.4

Any comorbidity1

237 (64.9)

250 (71.2)

0.07

Community-acquired infection

103 (29.5)

106 (32.8)

0.4

Source of infection

Pulmonary

186 (54.4)

165 (52.1)

0.5

Abdominal

84 (24.6)

108 (34.1)

0.007

Genitourinary

21 (6.1)

26 (8.2)

0.3

Soft tissue

47 (13.7)

24 (7.6)

0.01

Emergency admission

370 (99.5)

334 (94.4)

<0.001

Operative admission

89 (23.9)

114 (32.2)

0.01

SAPS without age and renal components

27.0 [21.0–36.0]

26.0 [19.0–34.0]

0.02

SOFA D1

9.0 [7.0–11.0]

9.0 [7.0–11.0]

0.08

APACHE II diagnostic group

 

  Respiratory tract, nonoperative

92 (24.7)

82 (23.2)

0.6

  Nonoperative sepsis

72 (19.4)

64 (18.1)

0.7

  Gastrointestinal tract, operative

56 (15.1)

71 (20.1)

0.08

  Gastrointestinal tract, nonoperative

32 (8.6)

30 (8.5)

0.9

  Cardiovascular, nonoperative

30 (8.1)

31 (8.8)

0.7

  Neurological, nonoperative

16 (4.3)

7 (2.0)

0.07

  Metabolic

16 (4.3)

7 (2.0)

0.07

  Trauma

12 (3.2)

5 (1.4)

0.1

  Neurological, operative

11 (3.0)

2 (0.6)

0.02

  Cardiovascular, operative

5 (1.3)

21 (5.9)

0.001

Treatment restrictions

  Any treatment restriction2

100 (26.9)

104 (29.4)

0.5

  Withholding of RRT

28 (7.5)

16 (4.5)

0.09

Outcomes

  Length of stay ICU (days)

4.1 [2.1–8.1]

4.7 [2.7–8.3]

0.09

  Length of stay hospital (days)

15.0 [8.0–25.0]

14.0 [7.0–24.0]

0.2

  90-day mortality

126 (33.9)

128 (36.2)

0.5

  Probability of death3

0.33 [0.17–0.62]

0.37 [0.17–0.64]

0.4

  SMR (95% CI)

0.72 (0.6–0.84)

0.66 (0.58–0.74)

 

Propensity for RRT4

0.06 [0.03–0.15]

0.06 [0.03–0.24]

0.01

  1. Values are expressed as count (%) and median [interquartile range], except for SMR (with 95% confidence interval). 1Including COPD, chronic cardiovascular disease, diabetes, thromboembolic disease, chronic liver disease, vasculitis, organ transplant, cancer; 2including withholding and withdrawing of intensive care, withholding and withdrawal of RRT, and do not resuscitate restrictions; 3calculated from SAPS II score; 4confounders entered to the propensity score: creatinine value on the first day in the ICU (D1), urine output on the D1, age, any comorbidity, SAPS II score without age and renal components and SOFA score without renal points on the D1. SOFA D1, Sequential Organ Failure Assessment on the first day in the ICU; APACHE II, Acute Physiology and Chronic Health Evaluation; SAPS II, Simplified Acute Physiology Score II; AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes; SMR, standardized mortality ratio.